Fluoroestradiol (FES)-Positron Emission Tomography (PET) imaging is a noninvasive measure of breast cancer estrogen-receptor (ER) expression. The results correlate well with standard biopsy and immunohistochemistry measurements and can predict the response of the tumor to endocrine therapy.
Related Journals of Fluroestradiol (FES)-Positron Emission Tomography
Tomography & Simulation, Brain Tumors & Neurooncology, Cervical Cancer: OpenAccess, Radiology, Neurology, Indian Journal of Radiology & Imaging.
